{"id":"https://openalex.org/W4404486969","doi":"https://doi.org/10.1038/s41551-024-01282-8","title":"Ablation of FAS confers allogeneic CD3\u2013 CAR T cells with resistance to rejection by T cells and natural killer cells","display_name":"Ablation of FAS confers allogeneic CD3\u2013 CAR T cells with resistance to rejection by T cells and natural killer cells","publication_year":2024,"publication_date":"2024-11-18","ids":{"openalex":"https://openalex.org/W4404486969","doi":"https://doi.org/10.1038/s41551-024-01282-8","pmid":"https://pubmed.ncbi.nlm.nih.gov/39558141"},"language":"en","primary_location":{"id":"doi:10.1038/s41551-024-01282-8","doi":"https://doi.org/10.1038/s41551-024-01282-8","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41551-024-01282-8","pdf_url":null,"source":{"id":"https://openalex.org/S2764624792","display_name":"Nature Biomedical Engineering","issn_l":"2157-846X","issn":["2157-846X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Biomedical Engineering","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056694033","display_name":"Silvia Menegatti","orcid":"https://orcid.org/0000-0002-8155-9169","observed_orcids":["https://orcid.org/0000-0002-8155-9169"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Silvia Menegatti","raw_affiliation_strings":["CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France"],"raw_orcid":"https://orcid.org/0000-0002-8155-9169","affiliations":[{"raw_affiliation_string":"CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079867161","display_name":"Sheila L\u00f3pez\u2010Cobo","orcid":"https://orcid.org/0000-0001-7920-0555","observed_orcids":["https://orcid.org/0000-0001-7920-0555"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sheila Lopez-Cobo","raw_affiliation_strings":["Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073483501","display_name":"Aur\u00e9lien Sutra Del Galy","orcid":"https://orcid.org/0000-0002-4716-1472","observed_orcids":["https://orcid.org/0000-0002-4716-1472"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Aurelien Sutra Del Galy","raw_affiliation_strings":["Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041916729","display_name":"Jaime R. Fuentealba","orcid":"https://orcid.org/0000-0001-5183-0707","observed_orcids":["https://orcid.org/0000-0001-5183-0707"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jaime Fuentealba","raw_affiliation_strings":["CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080970935","display_name":"Lisseth E. Silva","orcid":"https://orcid.org/0009-0008-7433-1255","observed_orcids":["https://orcid.org/0009-0008-7433-1255"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lisseth Silva","raw_affiliation_strings":["CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008330632","display_name":"La\u00ebtitia Perrin","orcid":"https://orcid.org/0009-0003-0633-6111","observed_orcids":["https://orcid.org/0009-0003-0633-6111"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laetitia Perrin","raw_affiliation_strings":["Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072204046","display_name":"Sandrine Heurtebise-Chr\u00e9tien","orcid":"https://orcid.org/0000-0003-1089-3829","observed_orcids":["https://orcid.org/0000-0003-1089-3829"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sandrine Heurtebise-Chr\u00e9tien","raw_affiliation_strings":["Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France"],"raw_orcid":"https://orcid.org/0000-0003-1089-3829","affiliations":[{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107401256","display_name":"Valentine Pottez-Jouatte","orcid":"https://orcid.org/0009-0003-3001-2096","observed_orcids":["https://orcid.org/0009-0003-3001-2096"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Valentine Pottez-Jouatte","raw_affiliation_strings":["CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025083136","display_name":"Aur\u00e9lie Darbois","orcid":"https://orcid.org/0000-0003-3022-8981","observed_orcids":["https://orcid.org/0000-0003-3022-8981"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Aurelie Darbois","raw_affiliation_strings":["Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071289285","display_name":"Nina Burgdorf","orcid":"https://orcid.org/0000-0003-4287-7751","observed_orcids":["https://orcid.org/0000-0003-4287-7751"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nina Burgdorf","raw_affiliation_strings":["Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082844803","display_name":"Anne-Laure Privat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne-Laure Privat","raw_affiliation_strings":["CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Albane Simon","orcid":"https://orcid.org/0009-0002-1281-3263","observed_orcids":["https://orcid.org/0009-0002-1281-3263"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Albane Simon","raw_affiliation_strings":["Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France"],"raw_orcid":"https://orcid.org/0009-0002-1281-3263","affiliations":[{"raw_affiliation_string":"Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005079102","display_name":"Marguerite Laprie-Sentenac","orcid":"https://orcid.org/0009-0001-6617-5052","observed_orcids":["https://orcid.org/0009-0001-6617-5052"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marguerite Laprie-Sentenac","raw_affiliation_strings":["Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France"],"raw_orcid":"https://orcid.org/0009-0001-6617-5052","affiliations":[{"raw_affiliation_string":"Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023665547","display_name":"Michael Saitakis","orcid":"https://orcid.org/0000-0002-6355-4225","observed_orcids":["https://orcid.org/0000-0002-6355-4225"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Saitakis","raw_affiliation_strings":["Mnemo Therapeutics, Paris, France"],"raw_orcid":"https://orcid.org/0000-0002-6355-4225","affiliations":[{"raw_affiliation_string":"Mnemo Therapeutics, Paris, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063681928","display_name":"Bryce J. Wick","orcid":"https://orcid.org/0000-0002-2844-0898","observed_orcids":["https://orcid.org/0000-0002-2844-0898"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bryce Wick","raw_affiliation_strings":["Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA","Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA","Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA"],"raw_orcid":"https://orcid.org/0000-0002-2844-0898","affiliations":[{"raw_affiliation_string":"Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516"]},{"raw_affiliation_string":"Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516"]},{"raw_affiliation_string":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010739155","display_name":"Beau R. Webber","orcid":"https://orcid.org/0000-0002-3950-8747","observed_orcids":["https://orcid.org/0000-0002-3950-8747"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beau R. Webber","raw_affiliation_strings":["Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA","Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA","Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA"],"raw_orcid":"https://orcid.org/0000-0002-3950-8747","affiliations":[{"raw_affiliation_string":"Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516"]},{"raw_affiliation_string":"Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516"]},{"raw_affiliation_string":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022057184","display_name":"Branden S. Moriarity","orcid":"https://orcid.org/0000-0002-3031-3767","observed_orcids":["https://orcid.org/0000-0002-3031-3767"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Branden S. Moriarity","raw_affiliation_strings":["Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA","Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA","Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA"],"raw_orcid":"https://orcid.org/0000-0002-3031-3767","affiliations":[{"raw_affiliation_string":"Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516"]},{"raw_affiliation_string":"Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516"]},{"raw_affiliation_string":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066882928","display_name":"Olivier J Lantz","orcid":"https://orcid.org/0000-0003-3161-7719","observed_orcids":["https://orcid.org/0000-0003-3161-7719"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Olivier Lantz","raw_affiliation_strings":["Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France"],"raw_orcid":"https://orcid.org/0000-0003-3161-7719","affiliations":[{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011516091","display_name":"Sebasti\u00e1n Amigorena","orcid":"https://orcid.org/0000-0001-8583-8416","observed_orcids":["https://orcid.org/0000-0001-8583-8416"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2746051580","display_name":"Universit\u00e9 Paris Sciences et Lettres","ror":"https://ror.org/013cjyk83","country_code":"FR","type":"education","lineage":["https://openalex.org/I2746051580"]},{"id":"https://openalex.org/I4210109573","display_name":"Immunit\u00e9 et Cancer","ror":"https://ror.org/01zefvs55","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Sebastian Amigorena","raw_affiliation_strings":["CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France. sebastian.amigorena@curie.fr","Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. sebastian.amigorena@curie.fr","Mnemo Therapeutics, Paris, France. sebastian.amigorena@curie.fr","CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","Mnemo Therapeutics, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France. sebastian.amigorena@curie.fr","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France. sebastian.amigorena@curie.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"raw_affiliation_string":"Mnemo Therapeutics, Paris, France. sebastian.amigorena@curie.fr","institution_ids":[]},{"raw_affiliation_string":"CellAction (Cell therapy Acceleration and Innovation), Institut Curie, Suresnes, France","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"Immunity and Cancer, Institut Curie, PSL University, INSERM U932, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I4210109573","https://openalex.org/I80043"]},{"raw_affiliation_string":"Mnemo Therapeutics, Paris, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080788742","display_name":"Laurie Menger","orcid":"https://orcid.org/0000-0003-0949-6607","observed_orcids":["https://orcid.org/0000-0003-0949-6607"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Laurie Menger","raw_affiliation_strings":["Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France. Laurie.MENGER@gustaveroussy.fr","Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France"],"raw_orcid":"https://orcid.org/0000-0003-0949-6607","affiliations":[{"raw_affiliation_string":"Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France. Laurie.MENGER@gustaveroussy.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2801843802"]},{"raw_affiliation_string":"Gustave Roussy, Paris-Saclay University, INSERM U1015, Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5011516091","https://openalex.org/A5080788742"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2746051580","https://openalex.org/I277688954","https://openalex.org/I2801843802","https://openalex.org/I4210109573","https://openalex.org/I80043"],"apc_list":{"value":12290,"currency":"USD","value_usd":12290},"apc_paid":null,"fwci":5.1377,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.97150949,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"8","issue":"12","first_page":"1651","last_page":"1664"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allogeneic-car-t-cells","display_name":"allogeneic CAR T cells","score":0.9160000085830688},{"id":"https://openalex.org/keywords/fas","display_name":"Fas","score":0.5910000205039978},{"id":"https://openalex.org/keywords/beta2-microglobulin","display_name":"beta2-microglobulin","score":0.7799999713897705},{"id":"https://openalex.org/keywords/hla-class-i","display_name":"HLA class I","score":0.5979999899864197},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.4699999988079071},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.5099999904632568},{"id":"https://openalex.org/keywords/immunocompetent-patient","display_name":"immunocompetent patient","score":0.7120000123977661},{"id":"https://openalex.org/keywords/crispr-knockout-screen","display_name":"CRISPR knockout screen","score":0.7910000085830688},{"id":"https://openalex.org/keywords/t-cell-survival","display_name":"T cell survival","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C139563560","wikidata":"https://www.wikidata.org/wiki/Q224930","display_name":"Natural killer T cell","level":4,"score":0.6636533737182617},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.663155734539032},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.6153228282928467},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.5875696539878845},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5676316618919373},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5604034662246704},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5346848964691162},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5215439796447754},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4941551983356476},{"id":"https://openalex.org/C149532602","wikidata":"https://www.wikidata.org/wiki/Q2409681","display_name":"Interleukin 12","level":4,"score":0.4864232540130615},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.4596099853515625},{"id":"https://openalex.org/C206191192","wikidata":"https://www.wikidata.org/wiki/Q17149636","display_name":"NK-92","level":5,"score":0.4467669427394867},{"id":"https://openalex.org/C67662055","wikidata":"https://www.wikidata.org/wiki/Q1047791","display_name":"Antigen-presenting cell","level":4,"score":0.4189555048942566},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3879733681678772},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3291929066181183},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.21623951196670532},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.17931586503982544},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006084","descriptor_name":"Graft Rejection","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017252","descriptor_name":"CD3 Complex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019014","descriptor_name":"fas Receptor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019014","descriptor_name":"fas Receptor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/s41551-024-01282-8","doi":"https://doi.org/10.1038/s41551-024-01282-8","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41551-024-01282-8","pdf_url":null,"source":{"id":"https://openalex.org/S2764624792","display_name":"Nature Biomedical Engineering","issn_l":"2157-846X","issn":["2157-846X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Biomedical Engineering","raw_type":"journal-article"},{"id":"pmid:39558141","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39558141","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature biomedical engineering","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2658974192","display_name":"Paris Sciences et Lettres","funder_award_id":"ANR-10-IDEX-0001","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"},{"id":"https://openalex.org/G6258609174","display_name":"Epigenetic re-programming of CAR T cells for solid tumors","funder_award_id":"ANR-21-RHUS-0016","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"}],"funders":[{"id":"https://openalex.org/F4320320883","display_name":"Agence Nationale de la Recherche","ror":"https://ror.org/00rbzpz17"},{"id":"https://openalex.org/F4320326454","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1839053269","https://openalex.org/W1976400767","https://openalex.org/W2028111124","https://openalex.org/W2039638023","https://openalex.org/W2042872673","https://openalex.org/W2050531443","https://openalex.org/W2054726996","https://openalex.org/W2062631578","https://openalex.org/W2100122648","https://openalex.org/W2116171543","https://openalex.org/W2131395804","https://openalex.org/W2159253287","https://openalex.org/W2179862924","https://openalex.org/W2188417157","https://openalex.org/W2414969937","https://openalex.org/W2588571054","https://openalex.org/W2589417329","https://openalex.org/W2616215756","https://openalex.org/W2787301955","https://openalex.org/W2801052048","https://openalex.org/W2809042973","https://openalex.org/W2913630852","https://openalex.org/W2969378520","https://openalex.org/W2991627551","https://openalex.org/W2996644149","https://openalex.org/W2998345757","https://openalex.org/W3003403042","https://openalex.org/W3017040524","https://openalex.org/W3041276616","https://openalex.org/W3046832427","https://openalex.org/W3082381897","https://openalex.org/W3094124272","https://openalex.org/W3124631812","https://openalex.org/W3201749743","https://openalex.org/W3216414181","https://openalex.org/W4283328628","https://openalex.org/W4308883689","https://openalex.org/W4366978070","https://openalex.org/W4380563796","https://openalex.org/W4386788883","https://openalex.org/W4387640843","https://openalex.org/W4388454471","https://openalex.org/W4400415576","https://openalex.org/W4412552366"],"related_works":["https://openalex.org/W4408825551","https://openalex.org/W4405096024","https://openalex.org/W4405646202","https://openalex.org/W4400415576","https://openalex.org/W4409119107","https://openalex.org/W4310099690","https://openalex.org/W4387499853","https://openalex.org/W4414947502","https://openalex.org/W4388048080","https://openalex.org/W4405039607"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2024-11-19T00:00:00"}